| Literature DB >> 30206291 |
Natsuko Inagaki1,2, Takeharu Hayashi3, Yasuyoshi Takei1, Kousuke Tanimoto4, Taishiro Chikamori1, Akinori Kimura5.
Abstract
Hypertrophic cardiomyopathy (HCM) is characterized by unexplained left ventricular hypertrophy. This study aimed to reveal the clinical and genetic backgrounds of the unique HCM with mid-ventricular obstruction (HCM-MVO) subtype. We identified 34 patients with HCM-MVO in our cohort, and about half (47%) of these patients experienced adverse events. We analyzed 67 cardiomyopathy-associated genes in the patients. In total, 44% of patients with HCM-MVO carried the cardiomyopathy-associated genetic variant (CAGV) in 14 genes. Only 21% of patients carried HCM-associated CAGVs in major sarcomere-encoding genes, while 18% of patients carried CAGVs in dilated cardiomyopathy/arrhythmogenic right ventricular cardiomyopathy-associated genes. CAGVs were more frequent in patients with asymmetric septal hypertrophy (ASH) than in those without ASH. These findings suggest that HCM-MVO is a high-risk group and may have different etiologies from typical HCM.Entities:
Mesh:
Year: 2018 PMID: 30206291 DOI: 10.1038/s10038-018-0509-9
Source DB: PubMed Journal: J Hum Genet ISSN: 1434-5161 Impact factor: 3.172